![]() |
市場調查報告書
商品編碼
2041745
基因預測工具市場預測至2034年—按組件、應用、最終用戶和地區分類的全球分析Gene Prediction Tools Market Forecasts to 2034 - Global Analysis By Component (Software and Service), Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球基因預測工具市場規模將達到 2.216 億美元,在預測期內以 20.3% 的複合年成長率成長,到 2034 年將達到 9.721 億美元。
基因預測工具是用於識別和註釋DNA序列中潛在蛋白質轉錄區的計算演算法。它們利用統計模型、隱馬可夫模型或機器學習技術分析基因序列,以預測基因、轉錄區、外顯子-內含子邊界和調控元件的位置。這些工具有助於理解遺傳結構,促進各種生物體的基因註釋、功能分析和基因組註釋,並對基因組學和分子生物學研究做出重大貢獻。
根據2021年生物資訊簡報,一種名為TSSFinder的程式被用來說明真核生物的啟動子序列。 TSSFinder是基於線性連接條件隨機場(LCCRF)的機率模型,用於預測初始轉錄起始點(TSS),該程序最初發表於文獻中。
對個人化醫療的需求日益成長
對個人化醫療日益成長的需求是推動基因預測工具進步的主要動力。這些工具利用基因資訊預測個體患有特定疾病的可能性、對特定藥物的反應、以及潛在的副作用。基因預測工具分析個體的基因數據,識別與疾病和藥物代謝相關的突變,從而幫助制定個人化的治療方案。
數據品質和複雜性
基因預測工具面臨基因組序列變異所帶來的資料品質挑戰,這會導致預測誤差。基因結構的複雜性,包括可變剪接和基因重複,進一步加劇了問題的複雜性,並影響預測的準確性。此外,海量的基因組數據也帶來了計算的挑戰,需要強大的演算法來處理各種不同的基因組特徵。因此,數據品質和複雜性的限制阻礙了基因預測的準確性,進而影響生物學解釋和後續分析。
生物資訊學的傳播
生物資訊學在基因預測工具的進步和廣泛應用方面發揮著至關重要的作用。透過利用計算演算法和生物數據,生物資訊學能夠實現精準的基因辨識、註釋和功能分析。它整合了序列分析、機器學習和統計方法,從而能夠破解遺傳密碼,並最佳化預測模型。對生物資訊學的日益依賴確保了基因預測工具在各個生物學研究領域中準確性、擴充性和可用性的提升。
嚴格的監管核准流程
基因預測工具嚴格的監理核准流程有許多弊端。它往往會延長研發週期,延緩基因研究和臨床應用領域的重大創新。高昂的監管門檻限制了工具的普及性和可負擔性,阻礙了小規模研究團隊和公司提供新的解決方案。此外,這些僵化的流程可能會優先考慮現有工具,從而扼殺創新,阻礙更有效或突破性技術的出現。
基因預測工具在識別病毒基因、突變和功能成分方面發揮了至關重要的作用。研究人員利用這些工具來篩選候選疫苗並評估其安全性和有效性。然而,疫情的蔓延導致資源重新分配、封鎖措施以及研究活動中斷,迫使許多與新冠肺炎無關的研究項目被取消或推遲。因此,基因預測工具在新冠肺炎以外的研究領域的應用速度有所放緩。
在預測期內,軟體領域預計將成為最大的細分市場。
在預測期內,軟體細分市場預計將佔據最大佔有率。這些工具利用先進的演算法分析基因組數據,並準確預測基因的位置、結構和功能。該市場的領導企業提供方便用戶使用的介面,方便研究人員和臨床醫生使用。軟體提高基因預測準確性的能力顯著推動了基因組研究和個人化醫療的發展,從而促進了市場擴張。隨著基因組數據的持續成長,對高效可靠的基因預測工具的需求預計將進一步加速市場成長。
在預測期內,診斷領域預計將呈現最高的複合年成長率。
在預測期內,診斷領域預計將呈現最高的複合年成長率。這些工具在識別疾病相關的基因變異和支持個人化醫療方面發揮著至關重要的作用。精準高效診斷解決方案的需求正在推動基因預測工具的創新,並形成競爭格局。領先企業致力於提高診斷準確性、拓展應用領域並增強用戶友善介面,從而促進市場的整體成長和發展。
預計北美將在預測期內佔據最大的市場佔有率。人們對基因研究的興趣和投資日益成長,尤其是在個人化醫療、癌症研究和農業等領域,這推動了對先進基因預測工具的需求不斷成長。該地區的生物技術和製藥公司正在基因編輯、治療和診斷等相關研發領域投入大量資金,進一步促進了市場成長。
預計亞太地區在整個預測期內將保持最高的複合年成長率。這一成長受多種因素驅動,包括基因組學領域研發活動的活性化、生物技術和製藥行業投資的成長以及人們對個人化醫療日益成長的認知。這些國家是該市場的主要驅動力,因為它們在生命科學研究方面投入巨大。這些國家擁有蓬勃發展的生物技術產業和學術機構,並進行廣泛的基因組學研究。
According to Stratistics MRC, the Global Gene Prediction Tools Market is accounted for $221.6 million in 2026 and is expected to reach $972.1 million by 2034 growing at a CAGR of 20.3% during the forecast period. Gene prediction tools are computational algorithms used to identify and annotate potential protein-coding regions within DNA sequences. They analyze genetic sequences, employing statistical models, hidden Markov models, or machine learning techniques to predict the locations of genes, coding regions, exon-intron boundaries, and regulatory elements. These tools aid in understanding genetic structures, facilitating gene annotation, functional analysis, and genome annotation in various organisms, contributing significantly to genomics and molecular biology research.
According to Briefings in Bioinformatics in 2021, a program called TSSFinder was used to describe the promoter sequences from Eukaryotic species. The initial transcription start site (TSS) prediction approach that uses a probabilistic model based on linear chain conditional random fields (LCCRFs) is TSSFinder, which was originally disclosed in the literature.
Rising demand for personalized medicines
The increasing demand for personalized medicine has been a driving force in the advancement of gene prediction tools. These tools utilize genetic information to predict an individual's likelihood of developing certain diseases, their response to particular medications, and potential adverse reactions. Gene prediction tools analyze an individual's genetic data to identify variations associated with diseases or drug metabolism, aiding in customizing treatment plans.
Data quality and complexity
Gene prediction tools face challenges with data quality due to variations in genome sequences, leading to errors in predictions. The complexity of gene structures, including alternative splicing and overlapping genes, adds intricacy, affecting accuracy. Moreover, the vast amount of available genomic data poses computational challenges, requiring robust algorithms to handle diverse genomic features. Consequently, limitations in data quality and complexities hinder precise gene predictions, impacting biological interpretations and downstream analyses.
Growing adoption of bioinformatics
Bioinformatics plays a pivotal role in advancing gene prediction tools, driving their widespread adoption. Leveraging computational algorithms and biological data, bioinformatics enables accurate gene identification, annotation, and functional analysis. Its integration optimizes predictive models, employing sequence analysis, machine learning, and statistical methods to decipher genetic codes. The growing reliance on bioinformatics ensures enhanced precision, scalability, and accessibility of Gene Prediction Tools in various biological research domains.
Stringent regulatory approval process
The stringent regulatory approval process for gene prediction tools poses several disadvantages. It often leads to prolonged development timelines, delaying crucial innovations in genetic research and clinical applications. High regulatory barriers limit accessibility and affordability, impeding smaller research groups or companies from contributing novel solutions. Additionally, these stringent processes may stifle innovation by favouring established tools, hindering the emergence of potentially more effective or groundbreaking technologies.
Gene prediction tools played a crucial role in identifying viral genes, mutations, and functional components. These tools were used by researchers to evaluate the safety and efficacy of possible vaccine candidates in addition to identifying them. However, as the epidemic spread, numerous research projects unrelated to COVID-19 had to be cancelled or postponed due to resource reallocation, lockdowns, and disruptions in research activity. Consequently, there was a deceleration in the acceptance and application of gene prediction instruments in research domains other than COVID-19.
The software segment is expected to be the largest during the forecast period
The software segment is expected to be the largest during the forecast period. These tools utilize sophisticated algorithms to analyze genomic data, accurately predicting gene locations, structures, and functions. Key players in this market offer user-friendly interfaces, ensuring accessibility for researchers and clinicians. The software's ability to enhance precision in gene prediction significantly contributes to advancements in genomics research and personalized medicine, driving the market's expansion. As genomic data continues to grow, the demand for efficient and reliable gene prediction tools is expected to further propel market growth.
The diagnostics segment is expected to have the highest CAGR during the forecast period
The diagnostics segment is expected to have the highest CAGR during the forecast period. These tools play a crucial role in identifying genetic variations associated with diseases, aiding in personalized medicine. The demand for accurate and efficient diagnostic solutions has spurred innovation in gene prediction tools, creating a competitive market landscape. Key players are focusing on improving diagnostic accuracy, expanding applications, and enhancing user-friendly interfaces, contributing to the overall growth and evolution of the market.
North America is projected to hold the largest market share during the forecast period. Growing interest and investment in genetic research, particularly in fields like personalized medicine, cancer research, and agriculture, have increased the demand for sophisticated gene prediction tools. Biotech and pharmaceutical companies in the region are investing heavily in research and development related to gene editing, therapeutics, and diagnostics, further propelling the market growth.
Asia Pacific is projected to hold the highest CAGR over the forecast period. Several factors were contributing to this expansion, including increased research and development activities in genomics, rising investments in biotechnology and pharmaceutical sectors, and growing awareness about personalized medicine. Countries were key contributors to this market due to their substantial investments in life sciences research. These nations had vibrant biotechnology industries and academic institutions conducting extensive genomic research.
Key players in the market
Some of the key players in Gene Prediction Tools market include AZoLifeSciences, Illumina, Inc., BGI Genomics, Geneious, Thermo Fisher Scientific, Inc., Genscript, Exiqon, Softberry Technologies, Qiagen NV, National Human Genome Research Institute, New England Biolabs, ERS Genomics, Horizon Discovery Ltd., Sangamo Therapeutics, Takara Bio Inc. and Merck KGaA.
In June 2023, Illumina, Inc. disclosed the AI software for predicting disease-causing genetic mutations in patients. Through this, the company has enhanced its product portfolio and revenue growth.
In March 2022, Illumina, Inc. announced the launch of TruSigh Oncology (TSO) Comprehensive (EU). It is an examination that assesses various tumor of a patient's malignancy.